期刊文献+

雾化吸入可必特与氨茶碱、地塞米松对尘肺患者肺通气功能影响的研究

Effect of Aerosol Inhalation of Combivent,Aminophylline and Dexamethasone on Pulmonary Ventilation Function of Patients with Pneumoconiosis
原文传递
导出
摘要 目的观察雾化吸入氨茶碱、地塞米松和可必特后对煤工尘肺患者肺通气功能的影响。方法将110例煤工尘肺患者随机分为2组,A组60例,雾化吸入氨茶碱、地塞米松;B组50例,雾化吸入可必特,每天2次,连续5 d后,比较2组雾化吸入前后肺通气功能的改变及不良反应。结果 A组的FVC、FEV1差异无统计学意义(P>0.05),B组的FVC、FEV1差异有统计学意义(P<0.01);药物不良反应2组比较,差异无统计学意义。结论氨茶碱、地塞米松雾化吸入对CWP患者肺通气功能的改善不明显;可必特雾化吸入对CWP患者肺通气功能有显著改善,2组药物不良反应发生率均较低。 [Objective] To observe the effect of aerosol inhalation of aminophylline,dexamethasone and combivent on pulmonary ventilation function of patients with coal workers pneumoconiosis(CWP).[Methods]110 CWP patients were randomly divided into two groups.Group A(60 cases) was treated with aerosol inhalation of aminophylline and dexamethasone,and group B(50 cases) was given aerosol inhalation of combivent,twice daily for 5 days.The changes of pulmonary ventilation function before and after aerosol inhalation and the adverse reactions of two groups were compared.[Results]There was no significant different in FVC and FEV-1between before and after aerosol inhalation in group A(P〉0.05),but the differences in FVC and FEV-1was significant in group B(P〈0.01).There was no significant different in adverse drug reactions between two groups.[Conclusion]The aerosol inhalation of aminophylline and dexamethasone has no obvious effect on the pulmonary ventilation function of CWP patients,but the aerosol inhalation of combivent may significantly improve the pulmonary ventilation function of CWP patients,and the incidences of adverse reaction in both groups were low.
作者 田占鹏
出处 《职业与健康》 CAS 2010年第20期2298-2300,共3页 Occupation and Health
关键词 氨茶碱、地塞米松 可必特 煤工尘肺 雾化吸入 Aminophylline Dexamethasone Combivent Coal workers pneumoconiosis Aerosol inhalation
  • 相关文献

参考文献5

二级参考文献9

  • 1Combivent Inhalation Aerosol Study Group. In chronic pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone, an 85-day multicenter trial. Chest,1994,105(5):1411-1419.
  • 2Van Schayok CP, Dompeling E, van Herwaarden CLA, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis:continuous or on demand:a randomized controlled study. Br Med J,1991, 303:1426-1431.
  • 3Ingram RH Jr, Wellman JJ, Machmahin J, et al. Relative contributions to large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol.J Clin Invest,1977, 59:696-703.
  • 4Skorodin MS. Beta-adrenergic agonists:a problem. Chest, 1993,103(5):1587-1590.
  • 5Houtmeyers E, Gosselink R, Gayan RG, et al. Effects of drugs on mucus clearance. Eur Respir J, 1999,14:452-467.
  • 6Rennards M. Alternative mechanisms for long-acting beta(2)-adrenergic agonist in COPD.Chest,2001,120(1):258-270.
  • 7Sichletidis L, Kottakis J, Maroou S, et al.Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD.Int J Clin Pract, 1999,53(3):185-188.
  • 8姚婉贞,王国扬,朱红,赵鸣武.吸入溴化异丙托品对慢性阻塞性肺疾病大鼠模型气道和肺组织M受体的影响[J].中华结核和呼吸杂志,1999,22(2):95-97. 被引量:8
  • 9慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103

共引文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部